Market closed

ResMed/RMD

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About ResMed

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Ticker

RMD

Trading on

NYSE

Industry

Health Care Equipment & Supplies

Employees

9,980

ResMed Metrics

BasicAdvanced
$35B
Market cap
34.11
P/E ratio
$6.92
EPS
0.66
Beta
$1.97
Dividend rate
0.90%
Dividend yield
$35B
0.66
$249.97
$132.24
1M
$1.97
2.589
1.181
17.244
17.967
27.65%
30.28%
12.70%
22.70%
34.113
7.407
7.13
22.58
26.979
0.83%
0.90%
10.95%
13.63%
13.59%
28.78%
6.49%

What the Analysts think about ResMed

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for ResMed stock.

ResMed Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

ResMed Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy RMD

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for ResMed stock?

ResMed (RMD) has a market cap of $35B as of October 10, 2024.

What is the P/E ratio for ResMed stock?

The price to earnings (P/E) ratio for ResMed (RMD) stock is 34.11 as of October 10, 2024.

Does ResMed stock pay dividends?

Yes, the ResMed (RMD) stock pays dividends to shareholders. As of October 10, 2024, the dividend rate is $1.97 and the yield is 0.9%. ResMed has a payout ratio of 27.65% on a trailing twelve-month basis.

When is the next ResMed dividend payment date?

The next ResMed (RMD) dividend payment date is unconfirmed.

What is the beta indicator for ResMed?

ResMed (RMD) has a beta rating of 0.66. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.